1 | ASCO | 2.51% | |
2 | Patients | 1.57% | |
3 | Risk | 1.25% | |
4 | May | 1.25% | |
5 | Cancer | 0.94% | |
6 | Status | 0.94% | |
7 | Study | 0.94% | |
8 | Treatment | 0.94% | |
9 | Use | 0.94% | |
10 | Disease | 0.94% | |
11 | Immune | 0.63% | |
12 | CDC | 0.63% | |
13 | Checkpoint | 0.63% | |
14 | Outcomes | 0.63% | |
15 | mCRPC | 0.63% | |
16 | Number | 0.63% | |
17 | Protein | 0.63% | |
18 | Salmonella | 0.63% | |
19 | New | 0.63% | |
20 | Report | 0.63% | |
21 | Efficacy | 0.63% | |
22 | Case | 0.63% | |
23 | Gene | 0.63% | |
24 | Data | 0.63% | |
25 | MIBC | 0.63% | |
26 | According | 0.63% | |
27 | Response | 0.63% | |
28 | Cardiovascular | 0.63% | |
29 | Versus | 0.63% | |
30 | Tumor | 0.63% | |
31 | Phase | 0.63% | |
32 | Stroke | 0.63% | |
33 | Retention | 0.31% | |
34 | Clear | 0.31% | |
35 | Caused | 0.31% | |
36 | Dog | 0.31% | |
37 | Strategies | 0.31% | |
38 | Signs | 0.31% | |
39 | Tied | 0.31% | |
40 | Deaths | 0.31% | |
41 | Effectiveness | 0.31% | |
42 | Resistance | 0.31% | |
43 | Burden | 0.31% | |
44 | Syndrome | 0.31% | |
45 | Supernumerary | 0.31% | |
46 | Biomarkers | 0.31% | |
47 | Durvalumab | 0.31% | |
48 | Spacer | 0.31% | |
49 | Value | 0.31% | |
50 | Inhibitor | 0.31% | |
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
UC Davis clinical trial shows biomarkers hold clue in treating aggressive prostate cancer
FirstWord Pharma
2025-05-31 06:37:20
HER3-targeted antibody-drug conjugate shows promise for treatment-resistant solid tumors
Medical Xpress
2025-05-31 01:59:56